Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival

被引:56
作者
Lamkanfi, Mohamed [1 ]
Moreira, Lilian O. [1 ,2 ]
Makena, Patrudu [1 ]
Spierings, Diana C. J. [1 ]
Boyd, Kelli [3 ]
Murray, Peter J. [1 ,2 ]
Green, Douglas R. [1 ]
Kanneganti, Thirumala-Devi [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38104 USA
[2] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38104 USA
[3] St Jude Childrens Res Hosp, ARC Diagnost Lab, Memphis, TN 38104 USA
基金
美国国家卫生研究院;
关键词
MICE DEFICIENT; SEPTIC SHOCK; CELL-DEATH; SEPSIS; INTERLEUKIN-1-BETA; DISTINCT;
D O I
10.1182/blood-2008-09-178038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extensive apoptosis of leukocytes during sepsis and endotoxic shock constitutes an important mechanism linked to the excessive mortality associated with these disorders. Caspase inhibitors confer protection from endotoxin-induced lymphocyte apoptosis and improve survival, but it is not clear which caspases mediate lipopolysaccharide (LPS)-induced lymphocyte apoptosis and mortality. We report here that the apoptotic executioner caspase-7 was activated in the splenocytes of LPS-injected mice, suggesting a role for caspase-7 in lymphocyte apoptosis. Indeed, caspase-7-deficient mice were resistant to LPS-induced lymphocyte apoptosis and were markedly protected from LPS-induced lethality independently of the excessive production of serum cytokines. These results reveal for the first time a nonredundant role for caspase-7 in vivo and identify caspase-7 inhibition as a component of the mechanism by which caspase inhibitors protect from endotoxin-induced mortality. (Blood. 2009;113:2742-2745)
引用
收藏
页码:2742 / 2745
页数:4
相关论文
共 25 条
  • [1] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [2] Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis?
    Chung, CS
    Xu, YX
    Wang, WY
    Chaudry, IH
    Ayala, A
    [J]. ARCHIVES OF SURGERY, 1998, 133 (11) : 1213 - 1220
  • [3] Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepis and multiple organ failure
    Felmet, KA
    Hall, MW
    Clark, RSB
    Jaffe, R
    Carcillo, JA
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (06) : 3765 - 3772
  • [4] Many cuts to ruin:: a comprehensive update of caspase substrates
    Fischer, U
    Jänicke, RU
    Schulze-Osthoff, K
    [J]. CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) : 76 - 100
  • [5] Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock
    Gautier, Emmanuel L.
    Huby, Thierry
    Saint-Charles, Flora
    Ouzilleau, Betty
    Chapman, M. John
    Lesnik, Philippe
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (10) : 6941 - 6946
  • [6] Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock
    Grobmyer, SR
    Armstrong, RC
    Nicholson, SC
    Gabay, C
    Arend, WP
    Potter, SH
    Melchior, M
    Fritz, LC
    Nathan, CF
    [J]. MOLECULAR MEDICINE, 1999, 5 (09) : 585 - 594
  • [7] Apoptosis and caspases regulate death and inflammation in sepsis
    Hotchkiss, Richard S.
    Nicholson, Donald W.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) : 813 - 822
  • [8] Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
    Hotchkiss, RS
    Swanson, PE
    Freeman, BD
    Tinsley, KW
    Cobb, JP
    Matuschak, GM
    Buchman, TG
    Karl, IE
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (07) : 1230 - 1251
  • [9] Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
    Hotchkiss, RS
    Chang, KC
    Swanson, PE
    Tinsley, KW
    Hui, JJ
    Klender, P
    Xanthoudakis, S
    Roy, S
    Black, C
    Grimm, E
    Aspiotis, R
    Han, Y
    Nicholson, DW
    Karl, IE
    [J]. NATURE IMMUNOLOGY, 2000, 1 (06) : 496 - 501
  • [10] Hotchkiss RS, 1999, J IMMUNOL, V162, P4148